Get started
Author

SHAN-WEN LUI

Observed names: Shan-Wen Lui, Shan‐Wen Lui
ORCID: 0009-0002-1151-6814
Observed ORCID: 0009-0002-1151-6814
OpenAlex ID: A5034400235
Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis
2023 · TING-YU HSIEH, SHAN-WEN LUI, et al. · In Vivo · 19
PDF
Predicting the clinical efficacy of JAK inhibitor treatment for patients with rheumatoid arthritis based on Fas+ T cell subsets
2023 · Shan‐Wen Lui, Ting‐Yu Hsieh, et al. · Apmis · 18
Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report
2024 · SHAN-WEN LUI, JENG-WEI LU, et al. · In Vivo · 15
Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation
2025 · TING-HAO TU, JENG-WEI LU, et al. · In Vivo · 13
Molecular Hydrogen Therapy in Sjögren’s Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell
2024 · YUN-TING LIN, JENG-WEI LU, et al. · In Vivo · 12
PDF
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells
2024 · JING-YUAN CHEN, JENG-WEI LU, et al. · In Vivo · 11
Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren’s Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction
2025 · YING-HSUAN TSAI, JENG-WEI LU, et al. · In Vivo · 8
PDF
Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction
2025 · YUN-TING LIN, JENG-WEI LU, et al. · In Vivo · 8
Molecular Hydrogen as a Potential Adjunctive Therapy to Improve Renal Function and Reduce Fatigue in an Elderly Patient With Chronic Comorbidities: A Case Report
2024 · YUN-TING LIN, JENG-WEI LU, et al. · In Vivo · 7
PDF
Predicting Therapeutic Response to Molecular Hydrogen in Autoimmune Diseases via Immunophenotyping
2025 · Shan‐Wen Lui, Ting‐Yu Hsieh, et al. · Apmis · 6
PDF
Molecular Hydrogen Therapy Enhances Immune Markers in Treg, Plasma, Tr1 Cells, and KLRG1 Expression on Tc Cells: A Case of Acute SDH With Midline Shift and Uncal Herniation Post-decompressive Craniectomy
2025 · HUI-FU HSU, RUEI-YANG HU, et al. · In Vivo · 6
IVIG as a Promising Therapy for Methotrexate-induced Life-threatening Neutropenic Enterocolitis in an Elderly Patient With Rheumatoid Arthritis: A Case Report and Literature Review
2023 · SHAN-WEN LUI, JENG-WEI LU, et al. · In Vivo · 6
PDF
A Case Report of Adjuvant Molecular Hydrogen Therapy in Refractory Rheumatoid Arthritis With Atlantoaxial Subluxation
2025 · YOU-CHI REN, JENG-WEI LU, et al. · In Vivo · 4
PDF
Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis
2023 · Ting-Yu Hsieh, Jun-Fu Lin, et al. · Clinica Chimica Acta · 4
Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report
2025 · CHIN LIU, JENG-WEI LU, et al. · In Vivo · 3
PDF
Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report
2025 · TING-HAO TU, JENG-WEI LU, et al. · In Vivo · 3
PDF
Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation
2025 · TING-HAO TU, JENG-WEI LU, et al. · In Vivo · 3
PDF
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization
2025 · YUN-TING LIN, JENG-WEI LU, et al. · In Vivo · 2
PDF
Genetic variation at rs11574891 and rs3125003 in NOTCH1 is associated with therapeutic efficacy of Janus kinase inhibitors in Taiwanese patients with rheumatoid arthritis
2025 · Shan-Wen Lui, Feng-Cheng Liu, et al. · International Immunopharmacology · 1
Precision Assessment of Anti-NMDA Receptor Encephalitis: A Case Report on Integrating Clinical Course, Immunophenotyping, and Comprehensive Symptomatology in a Pediatric Patient With Adjunctive Hydrogen Therapy
2024 · SHANG-CHIANG LIN, JENG-WEI LU, et al. · In Vivo · 1
PDF
In Vivo Dynamics of Immunoregulatory Lymphocyte Reconstitution: A Seven-year Longitudinal Study of Sustained Remission in Class IV Lupus Nephritis Following Rituximab Therapy
2026 · SHAU-JIE HUNG, JENG-WEI LU, et al. · In Vivo
PDF
Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report
2026 · CHEN-YU LIAO, JENG-WEI LU, et al. · In Vivo
PDF
Corrigendum to “Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis” [Clinica Chimica Acta 551 (2023) 117612]
2025 · Ting-Yu Hsieh, Jun-Fu Lin, et al. · Clinica Chimica Acta
Works count: 23
Citation count: 150
H-index: 8
I10-index: 6
Year
Topic
Type